Brooke Ringel and Eric McClafferty outline steps companies should take to ensure compliance with export controls.
Eric McClafferty and Brooke Ringel
Advertisement
Eric McClafferty is Partner, and Brooke Ringel is Senior Associate, at Kelley Drye (Washington, DC).
Articles by Eric McClafferty and Brooke Ringel
Advertisement
Latest Updated Articles
- Minimizing Liability with Export Control Compliance
February 21st 2017
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
2
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
3
When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026
4
FDA Reveals New Guidance for Streamlining Biosimilar Development
5